Skip to main content
. 2010 Mar 19;15(5):675–686. doi: 10.1007/s12192-010-0180-3

Table 1.

Characteristics of study population

Parameters Control (n = 417) CHD (n = 417)
ACS + SA (n = 417) ACS (n = 291) SA (n = 126)
Age, y 60.6 ± 9.9 60.5 ± 9.9 60.3 ± 10.2 61.2 ± 9.3
Sex, male/female 315/102 315/102 226/65 89/37
BMI, kg/m2 24.4 ± 3.4 24.5 ± 3.3 24.5 ± 3.39 24.5 ± 3.11
Blood pressure, mmHg
Systolic 132 ± 21.4 136 ± 21.9* 135 ± 22.1 138 ± 21.2**
Diastolic 83 ± 11.4 81 ± 13.6* 80 ± 13.7* 82 ± 13.6
Fasting glucose, mmol/L 5.36 ± 1.92 6.16 ± 2.52** 6.26 ± 2.60** 5.93 ± 2.31**
Total cholesterol, mmol/L 4.90 ± 1.32 4.56 ± 1.02** 4.57 ± 1.02** 4.54 ± 1.01**
Triglyceride, mmol/L 1.65 ± 1.37 1.81 ± 1.40 1.86 ± 1.51 1.70 ± 1.11
Smoking,% 62.6 67.2 63.2 75.4**
Alcohol drinking,% 29.9 21.4** 21.4** 21.6**
History of hypertension,% 35.7 74.6** 74.6** 74.6**
History of diabetes,% 6.9 29.7** 29.2** 30.9**
Family history of CHD,% 2.2 11.3** 11.7** 10.3**
Hsp70, ng/mL 1.76 (0.73-3.55) 3.54 (1.20-5.52)** 3.77 (1.33-6.02)**,**** 2.26 (1.01-4.73)*
Anti-Hsp70 antibody, µg/mL 297.93 (212.60-430.14) 260.35 (190.78-391.01)** 252.03 (179.71-371.17)**,**** 295.56 (220.12-434.17)

Variables are mean ± SD, percentage or median (25th-75th quartile)

*P < 0.05 vs. control

**P < 0.01 vs. control

***P < 0.05 vs. SA

****P < 0.01 vs. SA